|1||NCT02394496||Recruiting||Overcoming Endocrine Resistance in Metastatic Breast Cancer||
||396||Female||18 Years and older (Adult, Senior)||NCT02394496||GIM8-OVER
|OVER||November 2007||December 2016||January 2017||March 20, 2015||June 15, 2016||
|2||NCT01425294||Terminated||Collection of Efficacy and Safety Data of Chinese Patients Who Have Received Faslodex 250mg Treatment||
||231||Female||Child, Adult, Senior||NCT01425294||NIS-OCN-FAS-2011/1||August 1, 2011||January 30, 2016||January 30, 2016||August 30, 2011||December 5, 2017||
† Study has passed its completion date and status has not been verified in more than two years.